Reovirus for the treatment of neoplasia

Details Reovirus for the treatment of neoplasia Reovirus for the treatment of neoplasia

A - Human Necessities

61

K

A61K 35/76 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2508238

Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, and use of reovirus for manufacture of a medicament for the treatment of neoplasia, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, type 1 (e.g., strain Lang), type 2 (e.g., strain Jones), type 3 (e.g., stain Dearing or strain Abney), as well as other serotypes or strains of reovirus can be used. Combinations of more than one type and/or strain of reovirus can be used, as can reovirus from different species of animal. Either solid neoplasms or hematopoietic neoplasms can be treated.

Affiliated with

Also associated with

Rating

Reovirus for the treatment of neoplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reovirus for the treatment of neoplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reovirus for the treatment of neoplasia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1994030